ctrl K

Price Alert

Sonoma Pharmaceuticals In... (SNOA)

NASDAQ: SNOA · Real-Time Price · USD

5.07

-0.20 (-3.80%)

At close: Aug 15, 2025, 3:09 PM

Sonoma Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	5.37M	3.13M	3.82M	7.4M	4.22M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	147K	396K	578K	707K	875K
Receivables	3.76M	2.9M	2.57M	2.41M	2.81M
Inventory	2.92M	2.72M	2.86M	2.66M	2.53M
Other Current Assets	360K	262K	240K	218K	209K
Total Current Assets	12.65M	12.55M	13.8M	16.43M	12.98M
Property-Plant & Equipment	309K	651K	906K	879K	1.13M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.04M	2.19M	2.43M	2.42M	2M
Total Assets	13.69M	14.74M	16.23M	18.84M	14.99M
Account Payables	953K	607K	841K	1.64M	1.77M
Deferred Revenue	641K	478K	160K	1.28M	319K
Short-Term Debt	220K	323K	431K	808K	596K
Other Current Liabilities	487K	694K	566K	784K	367K
Total Current Liabilities	4.1M	3.72M	3.72M	5.82M	4.08M
Long-Term Debt	n/a	n/a	n/a	n/a	1.31M
Other Long-Term Liabilities	5.14M	4.71M	4.24M	3.84M	3.48M
Total Long-Term Liabilities	5.19M	4.88M	4.54M	4.33M	5.55M
Total Liabilities	9.28M	8.6M	8.25M	10.15M	9.62M
Total Debt	305K	608K	849K	1.37M	2.67M
Common Stock	n/a	2K	5K	2K	2K
Retained Earnings	-197.81M	-194.35M	-189.51M	-184.36M	-179.28M
Comprehensive Income	-4.38M	-2.72M	-3.42M	-4.31M	-4.58M
Shareholders Equity	4.41M	6.14M	7.98M	8.7M	5.36M
Total Investments	n/a	n/a	n/a	n/a	n/a